1. Home
  2. INAB vs SOAR Comparison

INAB vs SOAR Comparison

Compare INAB & SOAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$0.75

Market Cap

11.8M

Sector

Health Care

ML Signal

HOLD

SOAR

Volato Group Inc.

SELL

Current Price

$0.17

Market Cap

12.3M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
INAB
SOAR
Founded
2016
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
12.3M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
INAB
SOAR
Price
$0.75
$0.17
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $7.00
N/A
AVG Volume (30 Days)
69.2K
★ 1.5M
Earning Date
11-05-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 104.83
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$0.10
52 Week High
$2.73
$1.40

Technical Indicators

Market Signals
Indicator
INAB
SOAR
Relative Strength Index (RSI) 32.88 42.55
Support Level N/A $0.18
Resistance Level $1.50 $0.19
Average True Range (ATR) 0.08 0.02
MACD -0.01 -0.00
Stochastic Oscillator 9.62 25.07

Price Performance

Historical Comparison
INAB
SOAR

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

About SOAR Volato Group Inc.

SOAR AI Inc is an AI infrastructure and software company focused on the development and operation of AI infrastructure and AI-powered software solutions. The company is actively constructing an AI infrastructure campus in Ohio that combines data center infrastructure, high-density GPU compute, high-performance networking and related technology to support AI, machine learning and high-performance computing workloads. It also develops AI-powered operational systems for aviation businesses through its Aviation AI platform and operates Vaunt, a technology-enabled private aviation membership platform.

Share on Social Networks: